Back to Search Start Over

Mindfulness-based relapse prevention combined with virtual reality cue exposure for methamphetamine use disorder: Study protocol for a randomized controlled trial.

Authors :
Chen, Xi Jing
Wang, Dong Mei
Zhou, Li Dan
Winkler, Markus
Pauli, Paul
Sui, Nan
Li, Yong Hui
Source :
Contemporary Clinical Trials. Jul2018, Vol. 70, p99-105. 7p.
Publication Year :
2018

Abstract

Background Mindfulness-based relapse prevention (MBRP) is a method that combines cognitive behavioral relapse prevention with mindfulness practice. Research suggests that MBRP can effectively reduce withdrawal/craving in people with substance use disorder (SUD). An important part of MBRP is to practice mindfulness meditation to cope with high-risk situations for relapse, such as stimuli and situations associated with drug taking. Virtual reality cue exposure (VRCE) may be a complementary approach to MBRP as it allows for controlled and graded presentations of various high-risk situations with distal and proximal drug cues. The aim of the study is to investigate the effects of MBRP combined with VRCE, in comparison to MBRP alone or treatment as usual, on craving and emotional responses in people with methamphetamine use disorders. Method/design The study is a parallel randomized controlled study including 180 participants with methamphetamine use disorder. Three parallel groups will receive 8 weeks of MBRP combined with VRCE, MBRP alone, or treatment as usual, respectively. Craving, virtual cue reactivity, anxiety, depression, emotion regulation, mindfulness and drug-related attention bias will be assessed at pre-treatment, post-treatment, and 3 and 6 months of follow-up. Discussion This innovative study aims at investigating the effects of MBRP combined with VRCE in people with SUD. The combined intervention may have important clinical implications for relapse prevention due to its ease of application and high cost-effectiveness. This study may also stimulate research on the neuronal and psychological mechanisms of MBRP in substance use disorder. Trial registration number ChiCTR-INR-17013041. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
15517144
Volume :
70
Database :
Academic Search Index
Journal :
Contemporary Clinical Trials
Publication Type :
Academic Journal
Accession number :
129973132
Full Text :
https://doi.org/10.1016/j.cct.2018.04.006